This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
OBJECTIVES
To determine risk factors for death in patients with COVID-19 admitted to the main public sector hospital in Somalia and identify interventions contributing to improved clinical outcome in a low resource and fragile setting.
SETTING
Main public sector tertiary hospital in Mogadishu, Somalia.
PARTICIPANTS
All 131 laboratory confirmed COVID19 patients admitted to the main public tertiary hospital in Somalia between 30 March and 12 June 2020.
MAIN OUTCOME MEASURES
We extracted demographic and clinical data from hospital records of all 131 COVID19 patients admitted to hospital until their death or recovery. We used Kaplan Meier statistics to estimate survival probabilities and the logrank test to assess significant differences in survival between groups. We used the Cox proportional hazard model to estimate likelihood of death and assess the effect of risk factors on survival.
RESULTS
Of the 131 patients, 52 (40%) died in the hospital and 79 (60%) survived to discharge. The factors independently associated with increased risk of in-hospital death were: age ≥ 60 years survival probability on day 21 in patients < 60 years was 0.789 (95% confidence interval (CI): 0.658,0.874) compared with 0.339 (95% CI: 0.205,0.478) in patients ≥ 60 years; cardiovascular disease (survival probability 0.478 (95% CI: 0.332,0.610) in patients with cardiovascular disease compared with 0.719 (95% CI: 0.601, 0.807) in patients without cardiovascular disease); and non-invasive ventilation on admission patients who were not ventilated were significantly more likely to survive than those who were (P < 0.001).
CONCLUSION
Our study, which includes the largest cohort of COVID19 patients admitted to a single hospital in a sub-Saharan African country, confirms that underlying conditions and age are associated with increased risk of in hospital death in patients with COVID-19. Our results show the advantage of medical oxygen over non-invasive ventilation in the treatment of patients with severe COVID-19 symptoms.
BACKGROUND
The establishment of empirical evidence in the Eastern Mediterranean Region (EMR) necessitates the implementation of wide-scale studies to describe the demographic, clinical features, and severity profile ofCOVID-19 patients.
OBJECTIVE
Hence, this study aimed to to assess the patterns of COVID-19 severity and mortality in seven countries and to determine the risk factors of COVID-19 severity and mortality.
METHODS
This multi-country study was based on a retrospective review of medical records of hospitalized patients confirmed to have COVID-19. This study included data from Iraq, Pakistan, Sudan, Somalia, Morocco, Egypt, and Yemen. All demographic and clinical data were extracted from hospital records (paper files) by trained data collectors.
RESULTS
A total of 4141 patients were included in this study from seven countries. Comorbidities were reported by nearly half of the patients, with hypertension (HT)(24.7%)and diabetes (22.7%) being the most common. Older age, diabetes mellitus, hypertension, and heart diseases were significantly associated with COVID-19 severity and mortality. Ever smoking and renal diseases were significantly associated with severity but not mortality, while male gender, respiratory diseases, and malignancy were significantly associated with mortality but not severity.
CONCLUSIONS
The study confirmed the role of comorbidities and demographic features on the severity and mortality of COVID-19. Understanding the contributing factors ensures attentive care and informs clinical management of patients with poorer prognosis in early stages of
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.